Michelle Rosenzwajg
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: April 24, 2026
Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort.
Journal: Circulation
Published: April 06, 2026
PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.
Journal: Frontiers in immunology
Published: March 19, 2026
ER proteostasis failure in HYOU1 deficiency alters B cells, neutrophils, and interferon signalling.
Journal: Journal of human immunity
Published: December 28, 2025
ER proteostasis failure in HYOU1 deficiency alters B cells, neutrophils, and interferon signalling.
Journal: Journal of human immunity
Published: December 28, 2025
An immunometabolic signature of major depressive disorder in systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: December 10, 2025
Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis.
Journal: Journal of autoimmunity
Published: September 10, 2025
Immunologic Profiling Suggests an Association Between Treg Cell Dysfunction and Pain in Knee Osteoarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2025
Immunological Profiling suggests an Association between Treg dysfunction and Pain in Knee Osteoarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2025
IL-1β signaling modulates T follicular helper and regulatory cells in human lymphoid tissues.
Journal: JCI insight
Published: October 31, 2024
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.
Journal: Science advances
Published: September 13, 2024
Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: July 26, 2024
Last Updated: 09/26/2026